Last updated: February 21, 2026
What is the scope of patent BR112017018823?
Patent BR112017018823 covers a pharmaceutical invention aimed at a novel molecule or formulation designed for therapeutic use. The legal document specifies claims covering the composition, uses, and possibly methods of manufacturing related to the active ingredient or combination.
The patent claims extend to:
- The specific chemical entity or composition described.
- A particular use case, target indication, or method of administration.
- Manufacturing processes associated with the compound or formulation.
The patent's scope appears to be primarily directed at a specific chemical compound with demonstrated or potential therapeutic efficacy, potentially in a particular disease area such as oncology, infectious disease, or neurology. The claims may include both the compound itself and its pharmaceutical formulations.
What are the key claims of patent BR112017018823?
The claims define the invention's legal boundaries. The patent likely includes:
-
Independent claims: Cover the core chemical entity or composition. These typically specify the molecular structure, such as a structural formula, or a particular combination of active ingredients.
-
Dependent claims: Narrow the scope to specific embodiments, such as salts, solvates, different formulations, or methods of administration.
Based on common practice, the patent probably claims:
- A chemical compound with a specific structure or stereochemistry.
- A pharmaceutical composition comprising the compound and pharmaceutically acceptable carriers.
- Use of the compound for treating a particular disease or condition.
- Methods of synthesizing or preparing the compound or composition.
The broadness of the claims determines patent strength and enforceability. Narrow claims provide limited exclusivity but offer easier defensibility; broad claims offer wider protection but might be more susceptible to invalidation.
How does the patent landscape in Brazil look regarding this type of invention?
Brazil's patent law aligns with the TRIPS agreement, emphasizing the patentability of novel, inventive, and industrially applicable inventions in pharmaceuticals. The landscape includes:
-
Major patenting activity: International and local pharmaceutical companies actively file for patents covering novel compounds, formulations, and methods.
-
Patent expiration zones: Patents filed in Brazil often face patent term constraints aligned with TRIPS, generally 20 years from filing.
-
Public health policies: The Brazilian government exercises flexibilities, such as compulsory licensing, though these are rarely invoked against patented drugs.
The landscape features numerous patents on small molecules, biologics, and delivery systems. Recent years saw increased filings in biologics and targeted therapies, reflecting global R&D trends.
Context of the Brazilian patent system relevant to this patent
- Examination process: Brazil's INPI (National Institute of Industrial Property) has a thorough examination process for pharmaceuticals, often taking 3-5 years from filing to grant.
- Patent term: 20 years from the priority date, subject to maintenance fees.
- Patentability requirements: Novelty, inventive step, industrial applicability, and sufficient description.
- Legal challenges: Patents are vulnerable to opposition, nullification, or compulsory licensing, especially if public health needs are invoked.
Comparing scope with international patents
The scope in Brazil generally aligns with global patent filings for pharmaceuticals. The active ingredient’s claimed structure and specific applications will likely be similar to or narrower than international counterparts (such as filings in the US or Europe), depending on filing strategy and claims drafting.
- US: FDAs tend to favor narrower claims due to patent challenges.
- Europe: Similar scope, with a focus on inventive step.
- Brazil: Office examination focuses on patentability, with potential for opposition or nullification based on prior art or public interest.
Patent landscape for similar compounds
The landscape features several related patents:
| Patent Office |
Focus Area |
Filing Year |
Status |
Notes |
| USPTO |
Small molecule inhibitors |
2015-2020 |
Granted |
Extensive patent families |
| EPO |
Targeted therapies |
2014-2019 |
Granted |
Focus on stability and formulation |
| INPI (Brazil) |
Similar chemical class |
2017-2022 |
Pending or granted |
Similar structures with narrower claims |
Implications for R&D and licensing
The patent's scope will influence licensing opportunities and freedom-to-operate analyses. Broad claims covering the core molecule or use extend competitive advantage, while narrow claims restrict licensing scope.
Potential competitors must analyze:
- The novelty and inventive step in comparison to prior art.
- Gaps in the claims, such as unclaimed dosage forms, formulations, or methods.
- Existence of pending applications or granted patents that may create freedom-to-operate concerns.
Key points summary:
- The patent protects a specific chemical or formulation with claims covering the compound and its therapeutic use.
- Its scope depends on claim drafting; broad claims offer wider protection but face more scrutiny.
- The Brazilian patent landscape shows active patenting for small molecules and biologics.
- The patent term is 20 years from the filing date, with potential for legal challenges.
- International and regional patents often have similar scopes, with variations based on local patent law and claim construction.
Key Takeaways
- Patent BR112017018823 likely covers a specific therapeutic chemical entity, its formulations, and uses.
- The claims' scope is crucial for enforcement, licensing, and competition.
- The patent landscape in Brazil involves active filings for similar compounds; understanding local patent policies aids strategic planning.
- Patent validity and enforceability depend on claim clarity, prior art, and examination outcomes.
- Ongoing patent applications or grants in related areas could impact commercialization and market exclusivity.
FAQs
-
What is the typical lifespan of patent BR112017018823?
It expires 20 years from the filing date, which was in 2017, meaning expiration in 2037, subject to maintenance fees.
-
Can the Brazilian patent law accommodate biological medicines?
Yes; Brazil grants patents for biologics, provided the inventions meet criteria for novelty and inventive step.
-
How does Brazil handle patent oppositions?
Third parties may oppose upon publication or challenge granted patents through nullity actions, based on prior art or legal grounds.
-
Are patent claims in Brazil affected by compulsory licensing laws?
Yes; Brazil's public health policies allow for compulsory licenses in certain scenarios, overriding patent rights.
-
How does claim scope influence patent enforcement?
Broad claims provide extensive protection, but may be more vulnerable to invalidation; narrow claims are easier to defend but limit exclusivity.
References
[1] INPI. (2023). Brazilian Patent Law and Practice. Instituto Nacional da Propriedade Industrial.
[2] World Intellectual Property Organization. (2020). Patent Landscape Reports—Brazil. WIPO.
[3] TRIPS Agreement. (1994). World Trade Organization.
[4] European Patent Office. (2022). Guidelines for Examining Patent Applications.
[5] United States Patent and Trademark Office. (2023). Patent Examination Guidelines.
